A FEASIBILITY STUDY OF GEMCITABINE AND BEVACIZUMAB IN WOMEN WITH PLATINUM-RESISTANT RECURRENT OVARIAN CANCER

被引：0
|
作者：
Nagao, S. [1 ]
Kogiku, A. [1 ,2 ]
Ota, M. [1 ]
Yamamoto, K. [1 ]
Narita, M. [1 ]
Shimada, K. [1 ]
Nagazawa, H. [1 ]
Shibutani, T. [1 ]
Yamamoto, K. [1 ]
Jimi, T. [1 ]
Yano, H. [1 ]
Kitai, M. [1 ]
Shiozaki, T. [1 ]
Matsuoka, K. [1 ]
Yamaguchi, S. [1 ]
机构：
[1] Hyogo Canc Ctr, Gynecol Oncol, Akashi, Hyogo, Japan
[2] Nishi Kobe Med Ctr, Obstet & Gynecol, Kobe, Hyogo, Japan
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2019年 / 29卷
关键词：
D O I：
10.1136/ijgc-2019-ESGO.982
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP936
引用
收藏
页码：A501 / A501
页数：1
相关论文
共 50 条
  • [1] Platinum-resistant recurrent ovarian cancer with long survival on bevacizumab and gemcitabine
    Komiyama, Shinichi
    Kugimiya, Tsuyoki
    Takeya, Chiaki
    Takahashi, Rena
    Kubushiro, Kaneyuki
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2018, 44 (07) : 1330 - 1334
  • [2] Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis
    Kazuki Takasaki
    Morikazu Miyamoto
    Masashi Takano
    Hiroaki Soyama
    Tadashi Aoyama
    Hiroko Matsuura
    Kento Kato
    Takahiro Sakamoto
    Mika Kuwahara
    Hideki Iwahashi
    Hiroki Ishibashi
    Tomoyuki Yoshikawa
    Kenichi Furuya
    [J]. Cancer Chemotherapy and Pharmacology, 2018, 81 : 809 - 814
  • [3] Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis
    Takasaki, Kazuki
    Miyamoto, Morikazu
    Takano, Masashi
    Soyama, Hiroaki
    Aoyama, Tadashi
    Matsuura, Hiroko
    Kato, Kento
    Sakamoto, Takahiro
    Kuwahara, Mika
    Iwahashi, Hideki
    Ishibashi, Hiroki
    Yoshikawa, Tomoyuki
    Furuya, Kenichi
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (05) : 809 - 814
  • [4] Platinum-gemcitabine-bevacizumab (PGA) for platinum-resistant/refractory recurrent ovarian cancer.
    Niu, Jiaxin
    Kundranda, Madappa N.
    Weiss, Glen J.
    Farley, John H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Feasibility of bevacizumab combined with gemcitabine in treatment of platinum-resistant epithelial ovarian cancer.
    Kogiku, Ai
    Nagao, Shoji
    Suzuki, Kazuhiro
    Yamamoto, Kasumi
    Senda, Tokihiro
    Kitai, Miho
    Shiozaki, Takaya
    Matsuoka, Kazuko
    Sudo, Tamotsu
    Yamaguchi, Satoshi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] EFFECTIVENESS OF BEVACIZUMAB IN PLATINUM-RESISTANT RECURRENT EPITHELIAL OVARIAN CANCER
    Pinto, R.
    Monteiro, S.
    Lima, B.
    Lopes, A. R.
    Abreu, M.
    Ferreira, M.
    Sousa, S.
    Redondo, P.
    Pereira, D.
    Savva-Bordalo, J.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A271 - A271
  • [7] A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
    Nagao, Shoji
    Kogiku, Ai
    Suzuki, Kazuhiro
    Shibutani, Takashi
    Yamamoto, Kasumi
    Jimi, Tomoatsu
    Kitai, Miho
    Shiozaki, Takaya
    Matsuoka, Kazuko
    Yamaguchi, Satoshi
    [J]. JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
  • [8] Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer
    Garcia, AA
    O'Meara, A
    Bahador, A
    Facio, G
    Jeffers, S
    Kim, DY
    Roman, L
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 93 (02) : 493 - 498
  • [9] A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
    Shoji Nagao
    Ai Kogiku
    Kazuhiro Suzuki
    Takashi Shibutani
    Kasumi Yamamoto
    Tomoatsu Jimi
    Miho Kitai
    Takaya Shiozaki
    Kazuko Matsuoka
    Satoshi Yamaguchi
    [J]. Journal of Ovarian Research, 13
  • [10] Phase II trial of pembrolizumab with cisplatin and gemcitabine in women with recurrent platinum-resistant ovarian cancer
    Walsh, C.
    Kamrava, M.
    Rogatko, A.
    Li, A. J.
    Cass, I.
    Karlan, B. Y.
    Rimel, B. J.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 16 - 17
12345